| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/30/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Common Stock | 3k | $0.94 | $2.8k | | 11/30/2022 |
| 08/01/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 130k | $1.57 | $204.1k | | 08/01/2022 |
| 02/15/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 130k | $3.19 | $414.7k | | 02/15/2022 |
| 09/16/2021 | Magenta Therapeutics, Inc. | MGTA | Sale | Common Stock | 5.7k | $6.73 | $38.6k | | 09/16/2021 |
| 09/14/2021 | Magenta Therapeutics, Inc. | MGTA | Grant | Common Stock | 20k | $0.00 | $0 | | 09/14/2021 |
| 11/02/2020 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 435k | $6.28 | $2.7M | | 11/02/2020 |
| 09/17/2019 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 82k | $8.83 | $724.1k | | 09/17/2019 |
| 03/04/2019 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 83k | $17.92 | $1.5M | | 03/04/2019 |
| 09/20/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 50k | $30.93 | $1.5M | | 09/20/2018 |
| 05/29/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Conversion | Class A Common Shares | 6.4k | $0.00 | $0 | | 05/29/2018 |
| 05/29/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Conversion | Series C Preferred Shares | 6.4k | $0.00 | $0 | | 05/29/2018 |
| 05/29/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Conversion | Class B Common Shares | 107k | $0.00 | $0 | | 05/29/2018 |
| 02/09/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Purchase | Series C Preferred Shares | 6.4k | $15.64 | $100k | | 05/29/2018 |